Cite
Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer
MLA
Noriko Suzuki, et al. “Interleukin 6 Receptor Is an Independent Prognostic Factor and a Potential Therapeutic Target of Ovarian Cancer.” PloS One, vol. 10, no. 2, Oct. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....74b24cbadf721bc721d0b70a31e9dd84&authtype=sso&custid=ns315887.
APA
Noriko Suzuki, Koji Nakamura, Tomonori Ogura, Hirohisa Kurachi, Tomoko Mizuno, Kenjiro Sawada, Tsuyoshi Ohta, Aki Isobe, Hiroshi Makino, Aska Toda, Seiji Mabuchi, Ikuko Sawada, Chifumi Ohyagi-Hara, Ken-ichirou Morishige, Erika Nakatsuka, Eiichi Morii, Yasuto Kinose, Tadashi Kimura, & Kae Hashimoto. (2014). Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer. PloS One, 10(2).
Chicago
Noriko Suzuki, Koji Nakamura, Tomonori Ogura, Hirohisa Kurachi, Tomoko Mizuno, Kenjiro Sawada, Tsuyoshi Ohta, et al. 2014. “Interleukin 6 Receptor Is an Independent Prognostic Factor and a Potential Therapeutic Target of Ovarian Cancer.” PloS One 10 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....74b24cbadf721bc721d0b70a31e9dd84&authtype=sso&custid=ns315887.